Paul J. Clancy
Chief Financial Officer, Biogen.
Companies
- Sionna Therapeutics, Inc.Board member Feb 6, 2025 to now1
- Xilio Therapeutics, Inc.Board member Oct 21, 2021 to now2
- Exact SciencesBoard member Mar 19, 2021 to now3
- IncyteBoard member Jan 22, 2015 to now4
- Agios PharmaceuticalsBoard member Sep 26, 2013 to Jun 23, 20225
- Alexion PharmaceuticalsChief financial officer Jul 12, 2017 to Jul 15, 20196
- BiogenChief financial officer Aug 21, 2007 to Apr 27, 20177
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Incyte INCY25,635 shares8$2.9M at $113.27Jun 30, 2026- Agios Pharmaceuticals AGIO6,549 shares9$205.1K at $31.32May 20, 2022
- Exact Sciences EXAS0 shares10Mar 23, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 30, 2026Granted 252 shares at $113.36 of Incyte8
- Jun 8, 2026Granted 1,642 shares of Incyte11
- May 19, 2026Sold 15,000 shares at $94.93 of Incyte12
- May 19, 2026Exercised options 15,000 shares at $84.53 of Incyte12
- Mar 31, 2026Granted 265 shares at $94.12 of Incyte13
- Mar 23, 2026Returned to company 5,398 shares of Exact Sciences10
- Mar 23, 2026Returned to company 20,640 shares of Exact Sciences10
- Dec 31, 2025Granted 241 shares at $98.77 of Incyte14
- Sep 30, 2025Granted 285 shares at $84.81 of Incyte15
- Jun 30, 2025Granted 361 shares at $68.10 of Incyte16
- Jun 12, 2025Granted 5,398 shares of Exact Sciences17
- Jun 10, 2025Granted 2,518 shares of Incyte18
- Mar 31, 2025Granted 358 shares at $60.55 of Incyte19
- Dec 31, 2024Granted 331 shares at $69.07 of Incyte20
- Sep 30, 2024Granted 368 shares at $66.10 of Incyte21
- Jun 28, 2024Granted 399 shares at $60.62 of Incyte22
- Jun 13, 2024Granted 5,444 shares of Exact Sciences23
- Jun 13, 2024Granted 5,939 shares of Exact Sciences24
- Jun 12, 2024Granted 2,830 shares of Incyte25
- Mar 28, 2024Granted 403 shares at $56.97 of Incyte26
- Dec 29, 2023Granted 412 shares at $62.79 of Incyte27
- Sep 29, 2023Granted 379 shares at $57.77 of Incyte28
- Jun 30, 2023Granted 380 shares at $62.25 of Incyte29
- Jun 14, 2023Granted 2,505 shares of Incyte30
- Jun 8, 2023Granted 3,599 shares of Exact Sciences31
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARExact Sciences, Board member
- 4SEC EDGARIncyte, Board member
- 5SEC EDGARAgios Pharmaceuticals, Board member
- 6
- 7SEC EDGARBiogen, Chief financial officer
- 8
- 9
- 10
- 11SEC EDGARForm 4 filed Jun 10, 2026
- 12SEC EDGARForm 4 filed May 21, 2026
- 13SEC EDGARForm 4 filed Apr 2, 2026
- 14SEC EDGARForm 4 filed Jan 5, 2026
- 15SEC EDGARForm 4 filed Oct 2, 2025
- 16SEC EDGARForm 4 filed Jul 2, 2025
- 17SEC EDGARForm 4 filed Jun 16, 2025
- 18SEC EDGARForm 4 filed Jun 12, 2025
- 19SEC EDGARForm 4 filed Apr 2, 2025
- 20SEC EDGARForm 4 filed Jan 3, 2025
- 21SEC EDGARForm 4 filed Oct 2, 2024
- 22SEC EDGARForm 4 filed Jul 2, 2024
- 23SEC EDGARForm 4 filed Jun 17, 2024
- 24SEC EDGARForm 4 filed Dec 20, 2024
- 25SEC EDGARForm 4 filed Jun 14, 2024
- 26SEC EDGARForm 4 filed Apr 2, 2024
- 27SEC EDGARForm 4 filed Jan 3, 2024
- 28SEC EDGARForm 4 filed Oct 3, 2023
- 29SEC EDGARForm 4 filed Jul 5, 2023
- 30SEC EDGARForm 4 filed Jun 16, 2023
- 31SEC EDGARForm 4 filed Jun 12, 2023